Imiquimod

Imiquimod Reactions 1680, p166 - 2 Dec 2017 Crusting and discomfort: case report A 51-year-old man experienced crusting and discomfort during treatment with imiquimod [duration of treatment to reaction onset and outcome not stated]. The man presented with intense pruritic lesions on the penis, pubis, scrotum and gluteal region from three years. His history was significant for basal cell carcinoma on the bridge of the nose (treated with surgery), seborrhoeic dermatitis, idiopathic erythema nodosum and facial herpes simplex. Bases on his symptoms inverse psoriasis was suspected. Subsequently, he received acitretin and betamethasone, but no improvement was noted. Thereafter, investigations led to the diagnosis of extensive multifocal genital and perineal squamous cell carcinoma in-situ (SCCIS). Consequently, his treatment was started with 5% topical imiquimod cream five times a week. However, after three months of therapy, little improvement was noted. Additionally, he was unable to tolerate a longer course due to crusting and discomfort, even with rotation of application sites. The man’s imiquimod therapy was switched to fluorouracil [5-fluorouracil]. Author comment: "The patient was treated with imiquimod cream 5% five times per week. Little improvement occurred after 3 months of therapy. A longer course, even with application site rotation, could not be tolerated because of crusting and discomfort." Worley B, et al. p16+ Squamous cell carcinoma in situ masquerading as genital psoriasis. JAAD Case Reports 3: 542-545, No. 6, Nov 2017. Available from: URL: http://doi.org/10.1016/j.jdcr.2017.07.017 - Canada 803284561 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Imiquimod

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/imiquimod-0ent1OurxG
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39097-2
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p166 - 2 Dec 2017 Crusting and discomfort: case report A 51-year-old man experienced crusting and discomfort during treatment with imiquimod [duration of treatment to reaction onset and outcome not stated]. The man presented with intense pruritic lesions on the penis, pubis, scrotum and gluteal region from three years. His history was significant for basal cell carcinoma on the bridge of the nose (treated with surgery), seborrhoeic dermatitis, idiopathic erythema nodosum and facial herpes simplex. Bases on his symptoms inverse psoriasis was suspected. Subsequently, he received acitretin and betamethasone, but no improvement was noted. Thereafter, investigations led to the diagnosis of extensive multifocal genital and perineal squamous cell carcinoma in-situ (SCCIS). Consequently, his treatment was started with 5% topical imiquimod cream five times a week. However, after three months of therapy, little improvement was noted. Additionally, he was unable to tolerate a longer course due to crusting and discomfort, even with rotation of application sites. The man’s imiquimod therapy was switched to fluorouracil [5-fluorouracil]. Author comment: "The patient was treated with imiquimod cream 5% five times per week. Little improvement occurred after 3 months of therapy. A longer course, even with application site rotation, could not be tolerated because of crusting and discomfort." Worley B, et al. p16+ Squamous cell carcinoma in situ masquerading as genital psoriasis. JAAD Case Reports 3: 542-545, No. 6, Nov 2017. Available from: URL: http://doi.org/10.1016/j.jdcr.2017.07.017 - Canada 803284561 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial